脑转移瘤的5-ALA荧光是局部复发和总生存的预后因素吗
该回顾性研究对218例脑转移瘤手术患者行5-ALA荧光引导切除并分析荧光行为与预后,完全切除者123/218例(56.4%),51例(23.4%)出现局部脑内进展;荧光阳性与阴性转移瘤的无进展生存(p=0.01)和总生存(20个月 vs 14个月,p=0.006)差异显著,作者认为荧光行为或可视为预后标志物,需进一步研究。
要点
- 218例脑转移瘤患者中完全切除123例(56.4%),51例(23.4%)出现局部脑内进展。
- 荧光阳性与阴性转移瘤总生存分别为20个月与14个月,差异显著(p=0.006)。
- 荧光阳性与阴性转移瘤无进展生存差异显著(p=0.01)。
核心结论
- 在本回顾性系列中,5-ALA荧光行为与局部无进展生存和总生存相关,或可视为预后标志物。
- 需进一步研究以评估脑转移瘤5-ALA诱导荧光行为的肿瘤学影响。
研究设计与样本
- 二次分析,纳入两项既往研究的136例患者更新随访资料,另新增82例患者。
- 所有患者均行脑转移瘤手术切除并术中评估5-ALA诱导荧光。
主要发现
- 218例符合纳入标准并分析,完全手术切除见于123/218例(56.4%)。
- 二分法手术切除程度(完全 vs 不完全或可疑完全切除)与二分法5-ALA荧光无关(p=0.66)。
- 51例(23.4%)在切除腔内或边缘出现局部脑内进展,其中8例为PpIX荧光转移瘤。
- PpIX非荧光转移瘤局部脑内进展较多的相关趋势(p=0.03)。
- 中位局部脑内进展时间4±11个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文自述为回顾性系列。
- 原文结论指出需进一步研究以评估5-ALA诱导荧光行为的肿瘤学影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: 5-Aminolevulinic acid (5-ALA) fluorescence-guided resection technique was first introduced for malignant glioma. However, the impact of the 5-ALA fluorescence behaviour of cerebral metastases is still unclear. Aim of this study was to determine the impact of PpIX-fluorescence on the local progression-free and overall survival. MATERIALS AND METHODS: A secondary analysis was performed and included an updated follow-up of 136 patients comprised in two previous studies. Additionally, 82 new patients were included. All patients underwent surgical resection of cerebral metastasis and intraoperative estimation of 5-ALA-induced fluorescence. The 5-ALA fluorescence behaviour of cerebral metastases was correlated with the rate of local recurrences, the local progression-free and overall survival. RESULTS: 218 patients suffering from cerebral metastatic spread fulfilled the inclusion criteria and were analysed: complete surgical resection could be achieved in 123/218 patients (56.4%). Dichotomised degree of surgical resection (complete vs. incomplete or questionable complete resection) was not related to dichotomized 5-ALA fluorescence of cerebral metastases (p = 0.66). 51 patients (23.4%) developed a local in-brain progression within or at the border of the resection cavity. Of these, 8 patients showed a PpIX-fluorescent metastasis. There was a trend towards a correlation between a higher local in-brain progression in PpIX-non-fluorescent metastases (p = 0.03). Median time to local in-brain progression was 4 ± 11 months. PpIX-fluorescent and PpIX-non-fluorescent metastases showed a significantly different progression-free survival (p = 0.01). PpIX-positive and -negative metastases showed a significantly different overall survival (20 and 14 months respectively; p = 0.006). CONCLUSION: The 5-ALA fluorescence behaviour was related to the local progression-free and the overall survival in the present retrospective series and might be considered a prognostic marker. Further studies are required to appreciate the oncological impact of the 5-ALA induced fluorescence behaviour of cerebral metastases.
引用
- Kamp MA, Munoz-Bendix C, Mijderwijk HJ, et al. Is 5-ALA fluorescence of cerebral metastases a prognostic factor for local recurrence and overall survival? J Neurooncol. 2018. PMID: 30535595. doi:10.1007/s11060-018-03066-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。